Exclusive negotiations for the acquisition of an European spinal entity
18 März 2021 - 6:00PM
Exclusive negotiations for the acquisition of an European spinal
entity
Press
release
Ecully, 18 March 2021 – 6 p.m.
Exclusive negotiations for the
acquisitionof a start-up in the field of spinal
surgery
Spineway, specialized in innovative
implants for the treatment of severe disorders of the spinal column
(spine), announces that it has entered exclusive negotiations with
a view to the acquisition of 100% of the capital of a European
start-up specialized in the design, manufacture and sale of
implants and instruments for spinal surgery.
With its founder having over 25 years’
experience in the spine field, the company has a line of products
for spinal fusions that it sells directly in France and via
distributors internationally.
In line with the Group’s growth strategy, this
acquisition will allow Spineway to consolidate its product range
and strengthen its positions in Europe by making a wider variety of
operating techniques with added value possible for spinal
surgeons.
Positioned on market segments representing 90%
of the use of spinal-surgery implants, this company has strong
growth potential in the current competitive environment and expects
its revenue to exceed €4M in three years1.
The project remains subject to several
conditions precedent, in particular audits resulting in
satisfactory reports. This acquisition would be financed in cash
and have the start-up’s team be integrated within the Group.
This acquisition should be finalized by the end
of May.
Upcoming: 15 April 2021
- Publication of Q1 2021 revenue
SPINEWAY IS ELIGIBLE FOR THE PEA-PME
(EQUITY SAVINGS PLANS FOR SMES)Find out all about Spineway
at www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.Spineway has an international network of
over 50 independent distributors and 90% of its revenue comes from
exports.Spineway, which is eligible for investment
through FCPIs (French unit trusts specializing in innovation), has
received the OSEO Excellence award since 2011 and has won the
Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation
award (2013) – INPI Talent award (2015). ISIN:
FR0011398874 - ALSPW
Contacts:
SPINEWAY Shareholder-services lineAvailable
Tuesday through Thursday(10 a.m. – 12 p.m.)+33 (0)811 045 555 |
Eligible PEA / PMEALSPWEuronext Growth |
AELIUM Finance et Communication Investor
relationsSolène Kennisspineway@aelium.fr |
1 Not audited
Spineway (EU:ALSPW)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Spineway (EU:ALSPW)
Historical Stock Chart
Von Apr 2023 bis Apr 2024